Prospective Study of Different Biological Tests (Multiplate, ROTEM) in a Cohort of Patients Followed for Essential Thrombocytemia (ET)
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 51
- 试验地点
- 2
- 主要终点
- Occurrence of thrombotic complications
研究概览
简要总结
There is no prospective study published on the Essential Thrombocythemia and the correlation between this specific disease, its complications and the biological variations observed.
The aim of this study is to demonstrate a correlation between biological tests of haemostasis, as Multiplate analyser and thromboelastometry (ROTEM) and the occurrence of clinical complications, thrombosis and/or haemorrhage, in order to determine if this biological tests could be biological prognostic factors
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Screening
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adult aged more than 18 years old
- •Patient followed in consultation for an Essential Thrombocythemia at diagnosis or during the follow-up
- •Collection of the informed consent
- •Patient affiliated to Social Security
排除标准
- •Patients aged less than 18 years old
- •Refusal of signature of the informed consent
- •Patients under guardianship
结局指标
主要结局
Occurrence of thrombotic complications
时间窗: every 4 months, up to 18 months
All thrombotic complications will be gathered by the investigators during the four months following the realization of Multiplate and ROTEM test
Occurrence of haemorrhagic complications
时间窗: every 4 months, up to 18 months
All haemorrhagic complications will be gathered by the investigators during the four months following the realization of Multiplate and ROTEM test
次要结局
- Occurrence of haemorrhagic complications(every 4 months, up to 18 months)
- Occurrence of thrombotic complications(every 4 months, up to 18 months)
- Changes of tests results according to medical treatments(every 4 months, up to 18 months)
- Description of platelet physiopathology(the day of inclusion)